One of the communities participating in the collaboration is NALMIN (Norwegian Advanced Light Microscopy Imaging Network) at the Faculty of Medicine, University of Oslo. NALMIN conducts research on advanced light microscopy.
“At NALMIN, we anticipate that the BioMedData collaboration will make it easier to share and analyse data obtained through advanced light microscopy,” says Professor Harald Stenmark.
Advanced light microscopy provides ultra-high-resolution images of molecules in microorganisms and cell cultures.
BioMedData and life sciences
Life science research has direct relevance for society and forms the basis for large parts of the economy in Norway, including the fish farming industry. The COVID-19 crisis has demonstrated precisely why researchers must be able to utilise research data from other researchers and that it must be possible to find and use the data in further research while complying with legal and privacy requirements. BioMedData will contribute to the above.
The research infrastructures in BioMedData will develop procedures to make it easier for researchers to publish important findings. It will also become easier to re-use bioinformatic tools and working methods.
The research communities that participate in BioMedData represent large parts of the Norwegian life science communities and involve a high proportion of research institutions. At the same time, BioMedData welcomes new partners and new research projects during the project period.
BioMedData is coordinated by ELIXIR Norway, the Norwegian node of ELIXIR, the pan-European research infrastructure for biological data. Several of the partner communities also rely on their respective European umbrella organisations.
BioMedData partners
The project runs from 1 June 2020 to 1 March 2024.
Norwegian research communities: ELIXIR Norway, National Consortium for Sequencing and Personalized Medicine (Norseq), Norwegian Molecular Imaging Infrastructure (NORMOLIM), Norwegian Advanced Light Microscopy Imaging Network (NALMIN), Biobank Norway, NOR-Openscreen, Norwegian Macromolecular Crystallography Consortium (NORCRYST), National network for advanced proteomic-infrastructure (NAPI), Norwegian Mother and Child Cohort Study Infrastructure (I-MoBa), National Infrastructure for Microbial Genomics (NIMG), Norwegian Infrastructure for Biodiversity Genomics (NIBIGEN)
Institutions involved: University of Bergen, University of OsloNorwegian University of Science and Technology (NTNU), University of Tromsø, Norwegian University of Life Sciences (NMBU), Centre for Molecular Medicine Norway, SINTEF, Oslo University Hospital, St Olav’s Hospital, Haukeland University Hospital, University Hospital of North Norway, Norwegian Institute of Public Health, Norwegian Directorate of eHealth, regional healthcare trusts, Norwegian Cancer Registry, Norwegian Institute for Water Research.